No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Basic Science
Participants needed
100 (estimated)
Sponsor
Well- Konnect Healthcare Services and Research Firm · Research network
Who this trial is looking for
This trial is looking for adults who have had COVID-19 and continue to experience symptoms after recovering from the initial illness. Participants will help researchers understand long-term effects of COVID-19 and explore new treatment possibilities.
Are You a Good Fit for This Trial?
You may be able to join if
I am at least 18 years old.
I have a positive COVID-19 diagnosis.
I have experienced symptoms for more than 4 weeks.
I can communicate in English or have a translator.
I can attend follow-up appointments.
I am willing to provide consent to participate.
You may not be able to join if
I am under 18 years old.
I have a history of myocarditis.
I have a history of pericarditis.
I have severe renal impairment.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Investigators are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition after testing positive for severe acute COVID-19 infection and are experiencing long-haul symptoms. The symptoms of long COVID can include extreme tiredness (fatigue), shortness of breath, memory and con…
Investigators are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition after testing positive for severe acute COVID-19 infection and are experiencing long-haul symptoms. The symptoms of long COVID can include extreme tiredness (fatigue), shortness of breath, memory and concentration issues (brain fog), heart palpitations, dizziness, joint pain, muscle aches, cough, headaches, anxiety, and depression.
It's important to note that there are various other symptoms that individuals can experience after a COVID-19 infection, such as loss of smell, chest pain or tightness, difficulty sleeping (insomnia), pins and needles, depression, anxiety, tinnitus, earaches, nausea, diarrhea, stomach aches, loss of appetite, cough, headaches, sore throat, and changes to the sense of smell or taste.
To be included in the study, participants must have had symptoms for more than 4 weeks. The goal of the study is to measure biomarkers, identify new ones through clinical trials, and individualize and optimize treatment plans, which may or may not include COVID-19 post-market antivirals, vaccines, and medical care.
It's essential to conduct thorough clinical trials to understand the long-term effects of COVID-19 and to develop personalized treatment plans for individuals experiencing long-haul symptoms.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Inclusion of Men, Women, and Minorities
* Participants must be at least 18 years old.
* Participants must have a positive COVID-19 diagnosis or clinical diagnosis of COVID-19
* Participants must have experienced persistent symptoms after recovering from the acute phase of the …
Inclusion Criteria:
* Inclusion of Men, Women, and Minorities
* Participants must be at least 18 years old.
* Participants must have a positive COVID-19 diagnosis or clinical diagnosis of COVID-19
* Participants must have experienced persistent symptoms after recovering from the acute phase of the illness.
* Participants must be willing to provide informed consent to participate in the study.
* Participants must be able to communicate effectively in English or have a translator available.
* Participants must be able to attend follow-up appointments as required by the study protocol.
* Participants must not have any medical conditions or take any medications that could interfere with the study results.
Exclusion Criteria:
* \>18 years of age
* Medical History of Myocarditis
* Medical History of Pericarditis
* Medical History of Severe renal impairment (eGFR \<30 mL/min).
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.